News tagged with cyclooxygenase family
Organometallic compounds as new drugs? Cobalt-containing aspirin complex with potential anti-tumor properties
Despite considerable progress in modern chemotherapy, there remains a large demand for innovative anti-tumor agents. A new approach involves modeling the pharmacological properties of established drugs with organometallic ...
Jan 13, 2009 |
2.8 / 5 (6) |
0
Search results for cyclooxygenase family
Turmeric might be 'the right spice' to fight colon cancer
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries — and ancient wisdom suggests that it's also good for your health. Taking this wisdom ...
Mar 02, 2011 |
4.8 / 5 (4) |
1
Breakthrough method predicts risk of invasive breast cancer
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) - the most common form of non-invasive breast cancer - are at risk of developing more invasive tumors in later ...
Apr 28, 2010 |
not rated yet |
2
Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects
In searching for a simple way to identify individuals with smoking-related lung injury, scientists at Weill Cornell Medical College have stumbled upon a potential explanation for why the class of pain-relievers known as COX-2 ...
Apr 30, 2009 |
not rated yet |
0
New Target for Maintaining Healthy Blood Pressure Discovered
(PhysOrg.com) -- In trying to understand the role of prostaglandins - a family of fatty compounds key to the cardiovascular system - in blood pressure maintenance, researchers at the University of Pennsylvania ...
Medicine & Health / Medical research
Apr 24, 2009 |
4.2 / 5 (5) |
0
A new century of Alzheimer's disease research
Imagine the day when a routine visit to the family doctor includes a simple blood test to predict the risk for developing Alzheimer’s disease (AD). If the test returns a worrisome result -- too many sticky brain proteins ...
Medicine & Health / Diseases, Conditions, Syndromes
Jul 25, 2007 |
4.9 / 5 (8) |
0
Study finds that vioxx reduces the risk of colorectal polyps
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX®) reduces the risk of colorectal adenomas, or polyps. Polyps are benign tumors that ...
Aug 30, 2006 |
4 / 5 (1) |
0
List of search results for cyclooxygenase family
